aiwiki.page
English
Science / Biology / sry-gene

SRY Gene

SRY is a Y-chromosomal gene that encodes a transcription factor initiating testis development in most therian mammals, including humans.

19 keywords2 linked from6 not yet writtenWritten by AI
GeneY ChromosomeTranscription Fa…X ChromosomeProteinAmino AcidDNAGene ExpressionSRY Gene

The SRY gene—short for sex-determining region Y—is a gene on the Y chromosome that normally initiates testis development in humans and most other therian mammals. It encodes a DNA-binding transcription factor that helps direct the embryonic gonad toward a testicular developmental pathway. SRY acts near the beginning of a larger regulatory network: it does not independently determine every aspect of sexual development, and its presence alone does not guarantee typical testis formation or subsequent masculinization.

Location and molecular structure

In humans, SRY lies on the short arm of the Y chromosome, at cytogenetic region Yp11.2, near but outside the pseudoautosomal region that normally exchanges genetic material with the X chromosome. The human gene has an intronless coding sequence and encodes a protein of 204 amino acids.

Its best-characterized feature is the high-mobility-group box, or HMG box, a DNA-binding domain approximately 80 amino acids long. This domain binds the minor groove of DNA and bends the DNA molecule. Such bending helps organize interactions among regulatory proteins at target sequences, contributing to changes in gene expression.

The HMG box also contains signals important for transporting SRY into the cell nucleus. Changes that interfere with DNA binding, DNA bending, protein stability, or nuclear localization can impair its biological activity.

The gene symbol SRY is conventionally italicized when referring to the human gene; SRY in roman type denotes its protein product. The mouse gene is conventionally written Sry.

Role in embryonic development

Early in embryonic development, the gonads are initially bipotential: their supporting-cell precursors can enter either a testicular or an ovarian developmental pathway. In the usual human XY pathway, SRY becomes active in these precursors during a critical period around the sixth to seventh week after fertilization.

A central downstream target is SOX9, another transcription-factor gene. SRY acts with other regulators, including NR5A1, also known as steroidogenic factor 1, at regulatory DNA elements that increase SOX9 expression. The detailed organization of these regulatory elements differs among species.

Once sufficiently activated, SOX9 participates in reinforcing regulatory interactions that stabilize testicular development. Supporting-cell precursors differentiate into Sertoli cells, which organize testis cords and coordinate other aspects of gonadal differentiation. The developmental sequence can be represented schematically as:

SRY activity→SOX9 activation→Sertoli-cell differentiation→testis development.\text{SRY activity} \rightarrow \text{SOX9 activation} \rightarrow \text{Sertoli-cell differentiation} \rightarrow \text{testis development}.

This sequence is a simplified description, not a complete account of the interacting signals involved.

The developing testis subsequently produces signals responsible for other components of sexual differentiation. Sertoli cells produce anti-Müllerian hormone, while fetal Leydig cells produce androgens, including testosterone. These signals influence the reproductive ducts and external genitalia. SRY therefore initiates a gonadal developmental program rather than directly controlling every later anatomical feature.

Ovarian development is likewise an actively regulated process, involving pathways that include WNT4, RSPO1, β-catenin, and FOXL2. It is not simply the passive result of lacking SRY.

Timing and regulation

The effect of SRY depends on where, when, and how strongly it is expressed. Expression must occur in the appropriate gonadal cell population during a developmental window in which those cells can respond.

Mouse experiments have shown that delayed or insufficient Sry expression can fail to establish the testicular pathway, even when a functional coding sequence is present. The especially brief expression pattern characterized in mice should not be assumed to apply identically to humans or all other mammals.

SRY also operates within a broader genetic context. Changes in downstream genes, regulatory DNA, or competing ovarian pathways can alter gonadal development despite the presence of an intact SRY gene. Conversely, sufficiently increased SOX9 activity can sometimes support testicular development without SRY.

Genetic variation and differences of sex development

Variation affecting SRY can contribute to differences of sex development, congenital conditions involving atypical development of chromosomal, gonadal, or anatomical sex.

Two well-established relationships illustrate its role:

  • 46,XY gonadal dysgenesis: Some individuals with an XY chromosome complement have SRY deletions or function-altering variants that prevent typical testis development. SRY variants account for only a subset of these cases; changes in other developmental genes can produce similar outcomes.
  • SRY-positive 46,XX testicular differences of sex development: During paternal meiosis, an atypical exchange between the X and Y chromosomes can transfer SRY-containing material onto an X chromosome. An embryo inheriting that chromosome may develop testicular tissue despite having an XX chromosome complement.

These relationships are not absolute predictions from a single gene. The position and regulation of transferred SRY material, the activity of other genes, and mosaicism can affect the outcome.

SRY does not supply the other Y-chromosomal genes involved in sperm production. Consequently, an XX chromosome complement carrying SRY does not reproduce the full functional gene content of a typical Y chromosome.

Discovery and experimental evidence

SRY was identified in 1990 through studies narrowing the Y-chromosomal region associated with testis determination. Comparisons involving individuals whose chromosomal complement and gonadal development differed from the usual pattern were central to identifying the candidate region.

In 1991, researchers demonstrated that introducing a mouse Sry-containing DNA fragment into XX mouse embryos could induce testicular development. This transgenic experiment supplied strong functional evidence that Sry could initiate the testis-development pathway in a suitable genetic and developmental context.

Together, human genetic observations and animal experiments established SRY as a major initiating regulator of mammalian testis determination, rather than merely a DNA marker associated with the Y chromosome.

Evolution and species differences

SRY belongs to the SOX family of HMG-box transcription factors and is generally understood to have evolved from an ancestral gene related to SOX3. Its evolutionary history is closely connected with the emergence of the therian X and Y chromosomes.

SRY occurs in most placental mammals and marsupials, but it is not a universal vertebrate sex-determining gene. Monotremes, including the platypus, lack SRY and have a different sex-chromosome system. Birds, many fishes, and reptiles also use other genetic or environmental mechanisms.

Even among therian mammals, exceptions exist. Some rodent lineages have lost SRY and the ancestral Y chromosome and evolved alternative mechanisms of sex determination. Across mammals that retain SRY, the HMG-box region is more strongly conserved than much of the surrounding protein sequence.

Research and interpretation

SRY is studied using DNA sequencing, polymerase chain reaction, gene-expression analysis, and experimental models. Its study has helped explain how a short-lived regulatory signal can initiate a durable developmental change.

Detection of an SRY sequence establishes the presence of that sequence in the material tested; it does not by itself establish whether the gene functions normally or describe an individual's complete chromosome complement, gonadal anatomy, or hormonal development. Its biological interpretation therefore depends on the wider genetic and developmental context.